J Korean Ophthalmol Soc.
1998 Feb;39(2):285-291.
Introduction of a New Therapeutic Modality for the Chronic Behcets Disease Patients: Synchronization of Plasmapheresis with Immune Modulation Therapy-
- Affiliations
-
- 1Department of Ophthalmology, Holy Family Hospital, The Catholic University of Korea, Puchun, Korea.
Abstract
- The Behcets disease patients with uveitis are oftern suffering from chronic recurrent inflammation resulting in the blindness. Etiology, prognosis, treatment modalities of this disease are various, and the factors, affecting the chronic long term prognosis are not clearly identified. Current treatment for Behcets disease is combination therapy : steroid with colchicine, cyclophosphamide, or cyclosporin. But these kinds of treatment was insufficient to change the disease process and often produced severe complications. Authors treated 4 cases of Behcets patients who had chronic progressive steroid resistent uveitis, with synchronizatin of plasmapheresis and immune modulation therapy. All of them showed marked improvement in uveal inflammatory reaction and visual acuity.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Chimeric Antigen Receptor T Cell Therapy: A Novel Modality for Immune Modulation
- A Clinical Application of Plasmapheresis in Bullous Pemphigoid
- A Case of Behcet's Disease Associated with Intestinal Ulcers
- A Case of Active Systemic Lupus Erythematosus Successful Treated with Plasmapheresis
- Plasmapheresis in a Patient With "Refractory" Urticarial Vasculitis
